These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 33984060

  • 1. Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
    Wolff E, Widgren K, Scalia Tomba G, Roth A, Lep T, Andersson S.
    PLoS One; 2021; 16(5):e0251644. PubMed ID: 33984060
    [Abstract] [Full Text] [Related]

  • 2. The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study.
    Kim S, Choi JK, Suh J, Park SH, Lee J.
    Vaccine; 2024 Jul 25; 42(19):4046-4055. PubMed ID: 38762358
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
    van Lier A, Lugnér A, Opstelten W, Jochemsen P, Wallinga J, Schellevis F, Sanders E, de Melker H, van Boven M.
    EBioMedicine; 2015 Oct 25; 2(10):1494-9. PubMed ID: 26629544
    [Abstract] [Full Text] [Related]

  • 5. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.
    Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O.
    BMC Public Health; 2015 Jun 05; 15():533. PubMed ID: 26041469
    [Abstract] [Full Text] [Related]

  • 6. Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?
    Bilcke J, van Hoek AJ, Beutels P.
    Hum Vaccin Immunother; 2013 Apr 05; 9(4):812-22. PubMed ID: 23321955
    [Abstract] [Full Text] [Related]

  • 7. An economic evaluation and incremental analysis of the cost effectiveness of three universal childhood varicella vaccination strategies for Ireland.
    Ahern S, Browne J, Murphy A, Teljeur C, Ryan M.
    Vaccine; 2024 May 22; 42(14):3321-3332. PubMed ID: 38609807
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
    Hoshi SL, Kondo M, Okubo I.
    Vaccine; 2017 May 31; 35(24):3264-3271. PubMed ID: 28479176
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model.
    Wolfson LJ, Daniels VJ, Pillsbury M, Kurugöl Z, Yardimci C, Kyle J, Dinleyici EC.
    PLoS One; 2019 May 31; 14(8):e0220921. PubMed ID: 31408505
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I, Santa-Olalla P, Lévy-Bruhl D.
    Rev Epidemiol Sante Publique; 2008 Oct 31; 56(5):323-31. PubMed ID: 18951741
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT.
    Hum Vaccin Immunother; 2016 Jul 02; 12(7):1766-76. PubMed ID: 26835890
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012.
    Kelly HA, Grant KA, Gidding H, Carville KS.
    Euro Surveill; 2014 Oct 16; 19(41):. PubMed ID: 25345520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.